Free Trial

Innospec (IOSP) Competitors

Innospec logo
$96.81 +0.21 (+0.22%)
Closing price 10/16/2026 04:00 PM Eastern
Extended Trading
$96.90 +0.09 (+0.10%)
As of 10/16/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IOSP vs. IBOC, UBSI, AVNT, CBT, and FNB

Should you buy Innospec stock or one of its competitors? Innospec's main competitors and comparable companies include International Bancshares (IBOC), United Bankshares (UBSI), Avient (AVNT), Cabot (CBT), and F.N.B. (FNB). Companies are selected based on similarities in market, industry, and size.

How does Innospec compare to International Bancshares?

International Bancshares (NASDAQ:IBOC) and Innospec (NASDAQ:IOSP) are related mid-cap companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations, dividends and media sentiment.

International Bancshares has higher earnings, but lower revenue than Innospec. International Bancshares is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
International Bancshares$1.06B3.97$412.29M$6.6310.16
Innospec$1.78B1.34$116.60M$4.9019.76

65.9% of International Bancshares shares are held by institutional investors. Comparatively, 96.6% of Innospec shares are held by institutional investors. 13.1% of International Bancshares shares are held by insiders. Comparatively, 1.5% of Innospec shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

International Bancshares has a net margin of 38.83% compared to Innospec's net margin of 6.60%. International Bancshares' return on equity of 12.67% beat Innospec's return on equity.

Company Net Margins Return on Equity Return on Assets
International Bancshares38.83% 12.67% 2.47%
Innospec 6.60%9.22%6.74%

International Bancshares pays an annual dividend of $1.46 per share and has a dividend yield of 2.2%. Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 1.9%. International Bancshares pays out 22.0% of its earnings in the form of a dividend. Innospec pays out 37.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. International Bancshares has raised its dividend for 16 consecutive years and Innospec has raised its dividend for 11 consecutive years. International Bancshares is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

International Bancshares has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, Innospec has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market.

International Bancshares currently has a consensus price target of $85.00, indicating a potential upside of 26.23%. Given International Bancshares' stronger consensus rating and higher possible upside, research analysts plainly believe International Bancshares is more favorable than Innospec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
International Bancshares
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Innospec
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, International Bancshares and International Bancshares both had 1 articles in the media. International Bancshares' average media sentiment score of 0.94 beat Innospec's score of 0.00 indicating that International Bancshares is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
International Bancshares
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Innospec
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

International Bancshares beats Innospec on 13 of the 18 factors compared between the two stocks.

How does Innospec compare to United Bankshares?

Innospec (NASDAQ:IOSP) and United Bankshares (NASDAQ:UBSI) are related mid-cap companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, dividends and risk.

United Bankshares has a consensus price target of $47.80, indicating a potential upside of 2.38%. Given United Bankshares' stronger consensus rating and higher probable upside, analysts plainly believe United Bankshares is more favorable than Innospec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innospec
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
United Bankshares
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43

United Bankshares has a net margin of 27.97% compared to Innospec's net margin of 6.60%. United Bankshares' return on equity of 9.39% beat Innospec's return on equity.

Company Net Margins Return on Equity Return on Assets
Innospec6.60% 9.22% 6.74%
United Bankshares 27.97%9.39%1.53%

Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 1.9%. United Bankshares pays an annual dividend of $1.52 per share and has a dividend yield of 3.3%. Innospec pays out 37.6% of its earnings in the form of a dividend. United Bankshares pays out 41.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Innospec has increased its dividend for 11 consecutive years and United Bankshares has increased its dividend for 26 consecutive years. United Bankshares is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

United Bankshares has lower revenue, but higher earnings than Innospec. United Bankshares is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innospec$1.78B1.34$116.60M$4.9019.76
United Bankshares$1.28B4.97$464.60M$3.6712.72

96.6% of Innospec shares are owned by institutional investors. Comparatively, 70.8% of United Bankshares shares are owned by institutional investors. 1.5% of Innospec shares are owned by company insiders. Comparatively, 3.2% of United Bankshares shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, United Bankshares had 2 more articles in the media than Innospec. MarketBeat recorded 3 mentions for United Bankshares and 1 mentions for Innospec. United Bankshares' average media sentiment score of 0.86 beat Innospec's score of 0.00 indicating that United Bankshares is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Innospec
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
United Bankshares
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Innospec has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, United Bankshares has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Summary

United Bankshares beats Innospec on 12 of the 19 factors compared between the two stocks.

How does Innospec compare to Avient?

Avient (NYSE:AVNT) and Innospec (NASDAQ:IOSP) are both mid-cap materials companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

Avient currently has a consensus price target of $46.38, suggesting a potential upside of 19.12%. Given Avient's stronger consensus rating and higher possible upside, research analysts plainly believe Avient is more favorable than Innospec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avient
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.71
Innospec
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Innospec has a net margin of 6.60% compared to Avient's net margin of 5.10%. Avient's return on equity of 11.64% beat Innospec's return on equity.

Company Net Margins Return on Equity Return on Assets
Avient5.10% 11.64% 4.67%
Innospec 6.60%9.22%6.74%

Avient pays an annual dividend of $1.10 per share and has a dividend yield of 2.8%. Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 1.9%. Avient pays out 59.5% of its earnings in the form of a dividend. Innospec pays out 37.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Avient has raised its dividend for 1 consecutive years and Innospec has raised its dividend for 11 consecutive years.

Innospec has lower revenue, but higher earnings than Avient. Innospec is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avient$3.26B1.10$81.90M$1.8521.04
Innospec$1.78B1.34$116.60M$4.9019.76

95.5% of Avient shares are owned by institutional investors. Comparatively, 96.6% of Innospec shares are owned by institutional investors. 0.9% of Avient shares are owned by company insiders. Comparatively, 1.5% of Innospec shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Avient had 14 more articles in the media than Innospec. MarketBeat recorded 15 mentions for Avient and 1 mentions for Innospec. Avient's average media sentiment score of 0.59 beat Innospec's score of 0.00 indicating that Avient is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Avient
4 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Innospec
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Avient has a beta of 1.28, meaning that its stock price is 28% more volatile than the broader market. Comparatively, Innospec has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

Summary

Avient beats Innospec on 11 of the 20 factors compared between the two stocks.

How does Innospec compare to Cabot?

Cabot (NYSE:CBT) and Innospec (NASDAQ:IOSP) are both mid-cap materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk.

Cabot has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market. Comparatively, Innospec has a beta of 0.9, indicating that its share price is 10% less volatile than the broader market.

Innospec has a net margin of 6.60% compared to Cabot's net margin of 5.23%. Cabot's return on equity of 20.29% beat Innospec's return on equity.

Company Net Margins Return on Equity Return on Assets
Cabot5.23% 20.29% 9.01%
Innospec 6.60%9.22%6.74%

In the previous week, Cabot and Cabot both had 1 articles in the media. Cabot's average media sentiment score of 0.40 beat Innospec's score of 0.00 indicating that Cabot is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cabot
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Innospec
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

93.2% of Cabot shares are owned by institutional investors. Comparatively, 96.6% of Innospec shares are owned by institutional investors. 3.1% of Cabot shares are owned by insiders. Comparatively, 1.5% of Innospec shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cabot pays an annual dividend of $1.89 per share and has a dividend yield of 2.5%. Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 1.9%. Cabot pays out 53.2% of its earnings in the form of a dividend. Innospec pays out 37.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cabot has raised its dividend for 14 consecutive years and Innospec has raised its dividend for 11 consecutive years. Cabot is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cabot presently has a consensus price target of $87.80, indicating a potential upside of 18.19%. Given Cabot's stronger consensus rating and higher possible upside, equities research analysts clearly believe Cabot is more favorable than Innospec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cabot
1 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14
Innospec
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Cabot has higher revenue and earnings than Innospec. Innospec is trading at a lower price-to-earnings ratio than Cabot, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cabot$3.71B1.03$331M$3.5520.93
Innospec$1.78B1.34$116.60M$4.9019.76

Summary

Cabot beats Innospec on 12 of the 18 factors compared between the two stocks.

How does Innospec compare to F.N.B.?

F.N.B. (NYSE:FNB) and Innospec (NASDAQ:IOSP) are related mid-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

F.N.B. has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market. Comparatively, Innospec has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

F.N.B. has a net margin of 22.29% compared to Innospec's net margin of 6.60%. Innospec's return on equity of 9.22% beat F.N.B.'s return on equity.

Company Net Margins Return on Equity Return on Assets
F.N.B.22.29% 9.10% 1.22%
Innospec 6.60%9.22%6.74%

79.3% of F.N.B. shares are owned by institutional investors. Comparatively, 96.6% of Innospec shares are owned by institutional investors. 1.5% of F.N.B. shares are owned by insiders. Comparatively, 1.5% of Innospec shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

F.N.B. currently has a consensus target price of $20.33, suggesting a potential upside of 17.87%. Given F.N.B.'s stronger consensus rating and higher probable upside, equities analysts clearly believe F.N.B. is more favorable than Innospec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
F.N.B.
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Innospec
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, F.N.B. had 10 more articles in the media than Innospec. MarketBeat recorded 11 mentions for F.N.B. and 1 mentions for Innospec. F.N.B.'s average media sentiment score of 0.08 beat Innospec's score of 0.00 indicating that F.N.B. is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
F.N.B.
1 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Innospec
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

F.N.B. has higher revenue and earnings than Innospec. F.N.B. is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
F.N.B.$1.83B3.33$565M$1.6810.27
Innospec$1.78B1.34$116.60M$4.9019.76

F.N.B. pays an annual dividend of $0.52 per share and has a dividend yield of 3.0%. Innospec pays an annual dividend of $1.84 per share and has a dividend yield of 1.9%. F.N.B. pays out 31.0% of its earnings in the form of a dividend. Innospec pays out 37.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Innospec has raised its dividend for 11 consecutive years. F.N.B. is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

F.N.B. beats Innospec on 12 of the 19 factors compared between the two stocks.

Get Innospec News Delivered to You Automatically

Sign up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IOSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IOSP vs. The Competition

MetricInnospecChemicals IndustryMaterials SectorNASDAQ Exchange
Market Cap$2.38B$11.34B$4.74B$12.68B
Dividend Yield1.90%2.98%4.78%32.08%
P/E Ratio19.7632.6923.5124.83
Price / Sales1.3451.1215,569.6672.37
Price / Cash13.6614.6924.8050.51
Price / Book1.803.129.315.85
Net Income$116.60M$231.65M$159.47M$381.63M
7 Day Performance1.21%-0.68%-2.55%-5.04%
1 Month Performance3.93%-2.95%-5.95%-8.02%
1 Year Performance30.68%16.51%12.35%-5.60%

Innospec Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IOSP
Innospec
2.7671 of 5 stars
$96.81
+0.2%
N/A+30.7%$2.38B$1.78B19.762,450
IBOC
International Bancshares
4.1539 of 5 stars
$69.34
-0.2%
$85.00
+22.6%
+2.7%$4.31B$1.06B10.462,319
UBSI
United Bankshares
3.2998 of 5 stars
$46.26
-0.4%
$47.80
+3.3%
+32.5%$6.31B$1.28B12.612,694
AVNT
Avient
4.0131 of 5 stars
$41.87
+0.6%
$46.71
+11.6%
+24.2%$3.84B$3.33B22.629,000
CBT
Cabot
4.1058 of 5 stars
$77.29
-0.1%
$87.80
+13.6%
+6.7%$3.99B$3.63B21.784,100

Related Companies and Tools


This page (NASDAQ:IOSP) was last updated on 10/18/2026 by MarketBeat.com Staff.
From Our Partners